SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-227070
Filing Date
2020-08-21
Accepted
2020-08-21 16:42:02
Documents
14
Period of Report
2020-08-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d68489d8k.htm   iXBRL 8-K 30625
2 EX-10.1 d68489dex101.htm EX-10.1 20056
3 EX-10.2 d68489dex102.htm EX-10.2 20154
  Complete submission text file 0001193125-20-227070.txt   206196

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20200817.xsd EX-101.SCH 3079
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20200817_lab.xml EX-101.LAB 18123
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20200817_pre.xml EX-101.PRE 11411
7 EXTRACTED XBRL INSTANCE DOCUMENT d68489d8k_htm.xml XML 3374
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 201123920
SIC: 8090 Services-Misc Health & Allied Services, NEC